Responses
Clinical/translational cancer immunotherapy
Original research
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.